Belite Bio BLTE
NASDAQ BLTE
$153.43 -1.02 (-0.66%)
As of: Oct 21, 2026 · 3:59 PM EDT

Belite Bio (BLTE) Operating Leases (2022 - 2025)

Updated

Belite Bio's Operating Leases was $188,000 in Q4 2025, down 28.0% from $261,000 a year earlier and down 23.3% from the prior quarter.

Analysis

Belite Bio (BLTE) Operating Leases (2022 - 2025) Analysis & Trends

From Q4 2022 onward, Belite Bio has reported Operating Leases for 5 quarters.

  • Operating Leases has now declined for three consecutive years, with a three-year compound annual growth rate of -34.5% (FY2022 to FY2025).
  • In earlier years, Operating Leases was $261,000 in FY2024 (-54.8%), $578,000 in FY2023 (-13.5%) and $668,000 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Belite Bio 5.16 Bn 5.16 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 188,000.00
Sep 30, 2025 245,000.00
Dec 31, 2024 261,000.00
Dec 31, 2023 578,000.00
Dec 31, 2022 668,000.00
API Access

Belite Bio Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=BLTE&period=max&api_key=YOUR_API_KEY